Investor Lists

Growth genomics investors

Updated 7 November 2026

Firms we have watched take part in a growth round raised by a genomics company in the last two years. Both the stage and the sector are what they did, not what their website says.

See all 41 →The top 25
41investors on the list+4 this week
1,876cheques in 12 months+14% against the market
$57Mmedian round they joined+606% against the market median
100%wrote a cheque in 12 months
85%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1New Enterprise AssociatesDeploying nowVC firm · United States1,610$34Mmedian roundOct 2026last seen
  2. 2Alumni VenturesDeploying nowVC firm · United States1,598$12Mmedian roundNov 2026last seen
  3. 3General CatalystDeploying nowVC firm · United States1,387$27Mmedian roundNov 2026last seen
  4. 4AccelDeploying nowVC firm · United States1,341$32Mmedian roundNov 2026last seen
  5. 5Khosla VenturesDeploying nowVC firm · United States1,128$26Mmedian roundNov 2026last seen
  6. 6Bessemer Venture PartnersDeploying nowVC firm · United States1,038$30Mmedian roundNov 2026last seen
  7. 7Google VenturesDeploying nowCorporate VC · United States884$38Mmedian roundOct 2026last seen
  8. 8VenrockDeploying nowVC firm · United States560$36Mmedian roundOct 2026last seen
  9. 9Tengxun TouziDeploying nowVC firm · China553$50Mmedian roundNov 2026last seen
  10. 10SeedcampDeploying nowVC firm · United Kingdom519$5Mmedian roundNov 2026last seen
  11. 11DCVCDeploying nowVC firm · United States431$29Mmedian roundNov 2026last seen
  12. 12Kleiner PerkinsDeploying nowVC firm · United States398$40Mmedian roundNov 2026last seen
  13. 13RA Capital ManagementDeploying nowPrivate equity · United States395$93Mmedian roundNov 2026last seen
  14. 14Temasek HoldingsDeploying nowVC firm · Singapore384$100Mmedian roundOct 2026last seen
  15. 15FirstMarkDeploying nowVC firm · United States319$20Mmedian roundOct 2026last seen
  16. 16Wellington ManagementDeploying nowVC firm · United States297$130Mmedian roundOct 2026last seen
  17. 17Janus Henderson InvestorsDeploying nowPrivate equity · United Kingdom178$115Mmedian roundOct 2026last seen
  18. 18T. Rowe PriceDeploying nowPrivate equity · United States136$400Mmedian roundNov 2026last seen
  19. 19HOF CapitalDeploying nowVC firm · United States101$15Mmedian roundNov 2026last seen
  20. 20Sound VenturesDeploying nowVC firm · Laos97$15Mmedian roundNov 2026last seen
  21. 21BaiduDeploying nowInvestment firm · China72$36Mmedian roundNov 2026last seen
  22. 22S16vcDeploying nowAngel network · United States58$11Mmedian roundJul 2026last seen
  23. 23LightrockDeploying nowVC firm · United Kingdom55$53Mmedian roundSept 2026last seen
  24. 24NVenturesDeploying nowCorporate VC · United States18$330Mmedian roundJun 2026last seen
  25. 25Samsung ElectronicsDeploying nowGrowth equity · South Korea18$145Mmedian roundSept 2026last seen
16 more on this list

All 41 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Reading for founders at Series B and scaling

More books for founders and investors on the Reading List.

As an Amazon Associate we earn from qualifying purchases.

Quick answers about growth genomics investors

Who are the most active growth genomics investors?

By cheques observed, the most active are New Enterprise Associates, Alumni Ventures, General Catalyst, Accel and Khosla Ventures.

How many growth genomics investors are there?

41 are on record. 100% made an investment in the last 12 months and 85% have led a round.

Which stages do growth genomics investors back?

Of the rounds with a named stage in the last 12 months, mostly Series A (25%) and Seed (19%).

How big are the rounds growth genomics investors join?

The typical (median) round among the leading investors here is $36M.

Which sectors do growth genomics investors back most?

In the last 12 months, mostly AI, Biotech and Fintech.

Which growth genomics investors lead the most rounds?

Accel (103 led), General Catalyst (97 led) and New Enterprise Associates (73 led).

Where are growth genomics investors based?

Among the most active, most are based in the United States (17), the United Kingdom (3) and China (2).

What have growth genomics investors invested in recently?

Recent rounds include Ocient (Series C, Nov 2026, with PSP Growth), Thinking Machines Lab (Other, Nov 2026, with Accel) and T-Therapeutics (Series B, Nov 2026, with Tengxun Touzi).

Built from the rounds we watched, refreshed every night. How we count · Report a correction